Cleary RK, Kassir A, Johnson CS, Bastawrous AL, Soliman MK, Marx DS, Giordano L, Reidy TJ, Parra-Davila E, Obias VJ, Carmichael JC, Pollock D, and Pigazzi A
Background: The primary objective of this study was to retrospectively compare short-term outcomes of intracorporeal versus extracorporeal anastomosis for minimally invasive laparoscopic and robotic-assisted right colectomies for benign and malignant disease. Recent studies suggest potential short-term outcomes advantages for the intracorporeal anastomosis technique., Methods: This is a multicenter retrospective propensity score-matched comparison of intracorporeal and extracorporeal anastomosis techniques for laparoscopic and robotic-assisted right colectomy between January 11, 2010, and July 21, 2016., Results: After propensity score-matching, there were a total of 1029 minimal invasive surgery cases for analysis-379 right colectomies (335 robotic-assisted and 44 laparoscopic) done with an intracorporeal anastomosis and 650 right colectomies (253 robotic-assisted and 397 laparoscopic) done with an extracorporeal anastomosis. There were no significant differences in any preoperative patient characteristics between groups. The minimally invasive intracorporeal anastomosis group had significantly longer operative times (p<0.0001), lower conversion to open rate (p = 0.01), shorter hospital length of stay (p = 0.02) and lower complication rate from after discharge to 30-days (p = 0.04) than the extracorporeal anastomosis group., Conclusions: This comparison shows several clinical outcomes advantages for the intracorporeal anastomosis technique in minimally invasive right colectomy. These data may guide future refinements in minimally invasive training techniques and help surgeons choose among different minimally invasive options., Competing Interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: Robert K Cleary MD is on the speaker’s bureau for Intuitive Surgical, Inc. Craig S Johnson MD is on the speaker’s bureau for Intuitive Surgical, Inc. and Pacira Pharmaceutical. Amir L Bastawrous MD is on the speaker’s bureau for Intuitive Surgical, Inc. Mark K Soliman MD is on the speaker’s bureau for Intuitive Surgical, Inc. Daryl S Marx MD is a proctor and observation site and is on the speaker’s bureau for Intuitive Surgical, Inc. Luca Giordano MD is a proctor and observation site for Intuitive Surgical, Inc. Eduardo Parra-Davila MD received a KCI research grant, and is a consultant for Medtronic, Inc. Johnson &Johnson, Inc., Titan, Inc., Bard Davol, Inc., Intuitive Surgical, Inc., Levita, Inc., and Storz, Inc. Vincent J Obias MD is a consultant for Intuitive Surgical, Inc. and Medrobotics, Inc. Joseph C Carmichael MD is on the speaker’s bureau for Johnson and Johnson, Inc., Medtronic, Inc., and Novadeq, Inc. He has also received honoraria from Medrobotics, Inc. for product development. Alessio Pigazzi, MD, is a consultant for Intuitive Surgical, Inc., Johnson and Johnson, Inc., and Medtronic, Inc. For the remaining authors, no disclosures were declared. All institutions received financial support from Intuitive Surgical, Inc. for data collection. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no restrictions on sharing data or materials.